Beyond Air (XAIR) 10-Q2019 Q1 Quarterly report

Filed: 14 Aug 18, 8:02am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: abandoned, advice, agency, air, ambient, asKokiCare, assessment, attestation, began, breach, breathing, capable, claim, collectively, Committee, Comparison, complaint, Concurrent, constant, contrast, counsel, Court, criteria, customary, decided, declaratory, demand, detailed, disease, Efficient, Empery, exemption, firm, fiscal, fixed, fourth, Framework, healthcare, hypertension, immaterial, issuable, lease, Lincoln, line, litigation, LLC, LP, LPC, lung, mask, Master, millstone, mistake, monetary, mutual, newborn, nitrogen, nonqualified, ofASC, offset, outcome, Park, partially, patient, persistent, pertaining, pool, PPHN, predicated, prevailing, proposed, provision, pursue, pursuing, reconciling, redemption, reduce, reformation, relief, resolution, responsible, Rule, satisfaction, satisfy, shorter, software, Sponsoring, stage, submission, suffering, Suit, Supreme, Tax, titrate, Tranche, transformative, Treadway, underlying, unmet, ventilator, vigorously, whichever, York

Removed: account, acquisition, Administration, aforesaid, agent, allocated, allocating, amendment, amortization, amortized, amounted, annually, apply, average, bank, base, BCF, beneficial, capitalized, case, CEO, CF, clearance, combination, commitment, comparable, composed, compounded, consideration, consultancy, consultant, consulting, convert, cystic, Deadline, debt, demonstrated, direct, discount, distinct, dosage, drug, eligible, employment, entitled, equipment, exclusivity, expiration, extension, failed, feature, federal, file, final, focusing, Food, forfeiture, fractional, gas, imputed, incremental, initial, initially, investment, IPO, limited, linked, loan, longer, mandatorily, maximum, nearest, NTM, operation, past, payment, Phase, pipeline, placement, planned, portion, practicable, presented, produced, proprietary, reduction, registrable, removed, repaid, replacing, resale, Reserve, respiratory, retired, retroactive, review, rounded, RSV, salary, SEC, separate, single, SPA, specific, strategic, study, supplier, supply, support, timely, treasury, treatment, unit, vasodilation, waived, weighted, yield

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

XAIR similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION

In connection with the accompanying Quarterly Report on Form 10-Q of AIT Therapeutics, Inc. for the period ended June 30, 2018 (the “Report”), the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:

(1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of AIT Therapeutics, Inc.

	/s/ Stephen DiPalma
	Stephen DiPalma Chief Financial Officer
	(Principal Financial and Accounting Officer)

August 14, 2018

The certification set forth above is being furnished as an Exhibit solely pursuant to Section 906 of the Sarbanes—Oxley Act of 2002 and is not being filed as part of the Report or as a separate disclosure document of AIT Therapeutics, Inc. or the certifying officers.